Chembio Diagnostics Inc. (NASDAQ:CEMI) currently has a daily average trading volume of 631.31K but it saw 933467 shares traded on Thursday. With a market cap of 12.11M USD, stock’s current market price of $0.33 came falling about -15.79 while comparing to the previous closing price of $0.39. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.24 and as low as $0.19. In the recent trading on the day, stock has struck highest price mark of $0.398 while lowest mark touched by it was $0.32.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
Taking a look at 20-day trading activity of Chembio Diagnostics Inc. (CEMI) gives us an average price of $0.4359, while its current price level is -73.39% below from 52-week high level whereas it is 73.68% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.3953 while that of 200 days or SMA-200 reads an average of $0.4879. A closer look into the stock’s movement over the week reveals that its volatility is standing at 12.01% during that period while stretching the period over a month that decreases to 3.44%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 21.85 which implies that the stock is in oversold territory.
The average price target assigned by the average number of analysts to a stock is a way to gauge worth of any stock in next 52 weeks. And in assigning price target to a stock, some analysts adopt a bearish approach by advocating lower-than-average price target which in this case is $8.00 while some adopt bullish approach by assigning higher-than-average price target which reads the price to top $8.00. Average price target assigned by them is $8.00 which highlights an upside potential of 95.88% for the stock over that period. And to attain the median price target of $8.00 assigned by those analysts, stock has to add about 95.88% of value to its current levels.
Craig Hallum upgraded its recommendation for the stock as a “Buy” from “Hold” on December 03, 2020 while assigning a price target range of $5-$10. Colliers Securities issued its recommendations for the stock as it upgraded the price target for the stock is $7.50.
Over the week, CEMI’s stock price is moving -25.71% down while it is -25.31% when we observe its performance for the past one month. Year-to-date it is 50.20% up and over the past year, the stock is showing a downside performance of -50.81%.
The latest quarterly earnings report issued by the company was for quarter ended 3/30/2022, when its quarterly earnings per share (EPS) of -$0.29 beaten by the consensus estimate of -$0.21 for the same. In next quarter, company is expected to be making quarterly sales of $11.2 million as analysts are expecting the sales for current fiscal year at $42.4 million and seeing the company making $38.09 million in sales next year. Moreover, analysts are in estimates of $9.16 million for current-quarter revenue.
Currently, Chembio Diagnostics Inc.’s total number of outstanding shares is 36.71M with 1.08% of that held by the insiders while 8.65% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -58.10% and return on equity (ROE) at -147.90%. Stock’s beta reads 1.86. Stock has a price to book (P/B) ratio of 0.60 while price to sale or P/S ratio amounts to 0.20. Its return on asset (ROA) is -57.30% on average.
